ZA987804B - A combination of a monoamine oxidase inhibitor and a H5-HT1b antagonists or agonist - Google Patents
A combination of a monoamine oxidase inhibitor and a H5-HT1b antagonists or agonistInfo
- Publication number
- ZA987804B ZA987804B ZA987804A ZA987804A ZA987804B ZA 987804 B ZA987804 B ZA 987804B ZA 987804 A ZA987804 A ZA 987804A ZA 987804 A ZA987804 A ZA 987804A ZA 987804 B ZA987804 B ZA 987804B
- Authority
- ZA
- South Africa
- Prior art keywords
- agonist
- combination
- monoamine oxidase
- oxidase inhibitor
- ht1b antagonists
- Prior art date
Links
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703376A SE9703376D0 (sv) | 1997-09-18 | 1997-09-18 | A new combination |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA987804B true ZA987804B (en) | 1999-03-18 |
Family
ID=20408296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA987804A ZA987804B (en) | 1997-09-18 | 1998-08-27 | A combination of a monoamine oxidase inhibitor and a H5-HT1b antagonists or agonist |
Country Status (27)
Country | Link |
---|---|
US (1) | US6159970A (xx) |
EP (1) | EP1014986B1 (xx) |
JP (1) | JP2001516719A (xx) |
KR (2) | KR20010024087A (xx) |
CN (1) | CN1278727A (xx) |
AR (1) | AR013503A1 (xx) |
AT (1) | ATE270889T1 (xx) |
AU (1) | AU752719B2 (xx) |
BR (1) | BR9812236A (xx) |
CA (1) | CA2302204A1 (xx) |
DE (1) | DE69825062T2 (xx) |
DK (1) | DK1014986T3 (xx) |
EE (1) | EE200000146A (xx) |
ES (1) | ES2222603T3 (xx) |
HU (1) | HUP0100621A2 (xx) |
ID (1) | ID25789A (xx) |
IL (1) | IL134775A0 (xx) |
IS (1) | IS5401A (xx) |
MX (1) | MXPA00002616A (xx) |
NO (1) | NO20001400L (xx) |
PL (1) | PL339368A1 (xx) |
PT (1) | PT1014986E (xx) |
SE (1) | SE9703376D0 (xx) |
SK (1) | SK2832000A3 (xx) |
TR (1) | TR200000725T2 (xx) |
WO (1) | WO1999013878A1 (xx) |
ZA (1) | ZA987804B (xx) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4957948A (en) * | 1988-05-05 | 1990-09-18 | Interface, Inc. | Biocidal protective coating for heat exchanger coils |
SE9601110D0 (sv) | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
WO2002066454A1 (en) * | 2001-02-21 | 2002-08-29 | Sankyo Company, Limited | Chromene derivatives |
US7504395B2 (en) * | 2001-07-20 | 2009-03-17 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
US20090054453A1 (en) * | 2006-03-17 | 2009-02-26 | Lilian Alcaraz | Novel Tetralins as 5-HT6 Modulators |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
WO2008065141A1 (en) | 2006-11-30 | 2008-06-05 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
ZA200905537B (en) | 2007-03-01 | 2010-10-27 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
JP5667440B2 (ja) | 2007-04-18 | 2015-02-12 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体 |
MX2012002993A (es) | 2009-09-11 | 2012-04-19 | Probiodrug Ag | Derivados heterociclicos como inhibidores de ciclasa glutaminilo. |
JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
MX2012010470A (es) | 2010-03-10 | 2012-10-09 | Probiodrug Ag | Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5). |
US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
WO2012123563A1 (en) | 2011-03-16 | 2012-09-20 | Probiodrug Ag | Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
EP3461819B1 (en) | 2017-09-29 | 2020-05-27 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
CN110179988A (zh) * | 2019-07-10 | 2019-08-30 | 王大伟 | 五羟色胺再摄取抑制剂和单胺氧化酶抑制剂联合在制备治疗抑郁症或早泄药物中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE204262T1 (de) * | 1991-09-18 | 2001-09-15 | Glaxo Group Ltd | Benzanilidderivate als 5-ht1d-antagonisten |
GB9119932D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
-
1997
- 1997-09-18 SE SE9703376A patent/SE9703376D0/xx unknown
-
1998
- 1998-08-27 ZA ZA987804A patent/ZA987804B/xx unknown
- 1998-09-09 CA CA002302204A patent/CA2302204A1/en not_active Abandoned
- 1998-09-09 ES ES98944376T patent/ES2222603T3/es not_active Expired - Lifetime
- 1998-09-09 BR BR9812236-3A patent/BR9812236A/pt not_active IP Right Cessation
- 1998-09-09 KR KR1020007002835A patent/KR20010024087A/ko active Search and Examination
- 1998-09-09 AU AU91931/98A patent/AU752719B2/en not_active Ceased
- 1998-09-09 MX MXPA00002616A patent/MXPA00002616A/es unknown
- 1998-09-09 HU HU0100621A patent/HUP0100621A2/hu unknown
- 1998-09-09 EE EEP200000146A patent/EE200000146A/xx unknown
- 1998-09-09 DK DK98944376T patent/DK1014986T3/da active
- 1998-09-09 IL IL13477598A patent/IL134775A0/xx unknown
- 1998-09-09 SK SK283-2000A patent/SK2832000A3/sk unknown
- 1998-09-09 AT AT98944376T patent/ATE270889T1/de not_active IP Right Cessation
- 1998-09-09 JP JP2000511500A patent/JP2001516719A/ja active Pending
- 1998-09-09 EP EP98944376A patent/EP1014986B1/en not_active Expired - Lifetime
- 1998-09-09 ID IDW20000522D patent/ID25789A/id unknown
- 1998-09-09 CN CN98811114A patent/CN1278727A/zh active Pending
- 1998-09-09 WO PCT/SE1998/001602 patent/WO1999013878A1/en active IP Right Grant
- 1998-09-09 PT PT98944376T patent/PT1014986E/pt unknown
- 1998-09-09 DE DE69825062T patent/DE69825062T2/de not_active Expired - Fee Related
- 1998-09-09 KR KR1020007002830A patent/KR20010024084A/ko not_active Application Discontinuation
- 1998-09-09 PL PL98339368A patent/PL339368A1/xx unknown
- 1998-09-09 TR TR2000/00725T patent/TR200000725T2/xx unknown
- 1998-09-09 US US09/171,578 patent/US6159970A/en not_active Expired - Fee Related
- 1998-09-17 AR ARP980104635A patent/AR013503A1/es unknown
-
2000
- 2000-03-14 IS IS5401A patent/IS5401A/is unknown
- 2000-03-17 NO NO20001400A patent/NO20001400L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SK2832000A3 (en) | 2000-09-12 |
DE69825062D1 (de) | 2004-08-19 |
PT1014986E (pt) | 2004-10-29 |
DE69825062T2 (de) | 2005-08-25 |
SE9703376D0 (sv) | 1997-09-18 |
EP1014986A1 (en) | 2000-07-05 |
AR013503A1 (es) | 2000-12-27 |
JP2001516719A (ja) | 2001-10-02 |
NO20001400L (no) | 2000-05-05 |
TR200000725T2 (tr) | 2000-08-21 |
ID25789A (id) | 2000-11-02 |
AU9193198A (en) | 1999-04-05 |
IS5401A (is) | 2000-03-14 |
ES2222603T3 (es) | 2005-02-01 |
IL134775A0 (en) | 2001-04-30 |
EP1014986B1 (en) | 2004-07-14 |
CA2302204A1 (en) | 1999-03-25 |
BR9812236A (pt) | 2000-07-18 |
WO1999013878A1 (en) | 1999-03-25 |
CN1278727A (zh) | 2001-01-03 |
AU752719B2 (en) | 2002-09-26 |
KR20010024084A (ko) | 2001-03-26 |
DK1014986T3 (da) | 2004-10-25 |
KR20010024087A (ko) | 2001-03-26 |
HUP0100621A2 (hu) | 2001-08-28 |
ATE270889T1 (de) | 2004-07-15 |
US6159970A (en) | 2000-12-12 |
PL339368A1 (en) | 2000-12-18 |
EE200000146A (et) | 2001-02-15 |
NO20001400D0 (no) | 2000-03-17 |
MXPA00002616A (es) | 2002-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA987804B (en) | A combination of a monoamine oxidase inhibitor and a H5-HT1b antagonists or agonist | |
EP1115389A4 (en) | ANTAGONISTS AND AGONISTS OF FRUCTOSAMINE OXIDASE | |
IL134776A0 (en) | A COMBINATION OF A 5-HT REUPTAKE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST | |
EP1009415A4 (en) | INHIBITORS OF $ g (b) -LACTAMASES AND THEIR USES | |
EP1083913A4 (en) | MONOAMINE OXIDASE (MAO) INHIBITORS AND USES THEREOF | |
PL337781A1 (en) | Antagonists and reverse antagonists of glucogene | |
HUP0101809A3 (en) | Inhibitors of type 5 and type 3 17betha-hydroxysteroid dehydrogenase and methods for their use | |
AU2764797A (en) | Somatostatin agonists and antagonists | |
EG21153A (en) | Use of oil and gasfield chemicals | |
PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
PL335054A1 (en) | Combination of agents for inhibiting carcinogenesis comprising benzimidazole and possibly a potentiator | |
AU4772497A (en) | Constrained somatostatin agonists and antagonists | |
IL117988A0 (en) | A new combination of an inhibitor and an antagonist | |
HUP9801227A3 (en) | Pharmaceutical compositions comprising monoamine oxidase b inhibitors and their use | |
PL341335A1 (en) | Combination of ace and mmp inhibitors | |
EP1069901A4 (en) | CALCILYTIC COMPOUNDS AND THEIR USE | |
ZA9810272B (en) | Formulation of a cobination of a opioid and a alpha-adrenergic agonist and the use thereof | |
GB9919130D0 (en) | Novel drilling device and method of use | |
EP1023269A4 (en) | BETA3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF USE | |
AU9640698A (en) | Pharmaceutical combination of a cyclooxigenase-2 inhibitor and acetaminophen or an opiate | |
HK1032740A1 (en) | A combination of a selective 5-ht1a antagonist and a selective h5-ht1b antagonist or partial agonist | |
HUP0201880A3 (en) | Pharmaceutical composition containing sibutramine and a lipase inhibitor | |
SI1021183T1 (en) | A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST | |
GB9700233D0 (en) | Use of glycosidase inhibitors | |
SI1014985T1 (en) | A combination of a 5-ht reuptake inhibitor and a h5-ht 1b antagonist or partial agonist |